Cristian Giancotti | Business Development [Contact] Mr. Giancotti brings 10 years of experience in the IT operating in Italy and UK, where he developed several operations in the electronic entertainment market as a freelance. His experience includes working for a public business education company as statistic consultant and relations in the classic and luxury cars industry in Europe and USA. With an operational base in Italy, Mr. Giancotti works as Executive Consultant to the CEO. He is actually also involved in non-profit projects for disadvantaged. He holds a BSc in IT and Statistic with minors in Engineering at University of Naples Federico II.
Cristian Giancotti | Business Development Mr. Giancotti
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Madrigal Pharmaceuticals Rewards New Employees with Equity Awards
Overview of Equity Inducement Awards Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a leading biopharmaceutical organization, has recently initiated equity inducement awards to welcome new talent to its dynamic team. This initiative demonstrates Madrigal's commitment to fostering a strong workforce geared towards tackling significant health challenges related to metabolic...
Continue Reading
Boston Metal Welcomes Roy Harvey to Enhance Board Leadership
Boston Metal Appoints Industry Leader Roy Harvey Boston Metal, a prominent technology company that is transforming the landscape of global metals production, has made a significant move by appointing Roy Harvey to its Board of Directors. This decision is pivotal as Boston Metal gears up for the commercial rollout of its groundbreaking Molten Oxide Electrolysis (MOE)...
Continue Reading
RBL LLC Partners with Carnrite Ventures for Biotech Growth
RBL LLC Partners with Carnrite Ventures for Biotech Growth RBL LLC, a leading biotech venture creation studio, is excited to announce a significant investment from Carnrite Ventures. This partnership aims to enhance the rapid development of their robust pipeline of innovative therapeutic companies. According to Paul Wotton, the managing partner at RBL, "Carnrite's...
Continue Reading
OncoC4 and AcroImmune Merger: A Milestone in Immunotherapy
Introducing the OncoC4 and AcroImmune Merger OncoC4, Inc. has just announced a thrilling merger with AcroImmune, a strategic union that promises to significantly boost OncoC4's standing in the biopharmaceutical sector. This collaboration brings together two companies dedicated to pioneering advancements in cancer treatment, with a special focus on developing unique...
Continue Reading
Rezolve AI Celebrates Major Investment Transforming AI Landscape
Rezolve AI Excited About $30 Billion AI Investment Rezolve AI (NASDAQ: RZLV), well-known for its cutting-edge AI-driven commerce solutions, is enthusiastic about the recent announcement from Microsoft and BlackRock. These influential tech companies plan to invest $30 billion into AI infrastructure, a decision that could profoundly alter the landscape of the artificial...
Continue Reading